Alnylam Pharmaceuticals reported $235.86M in Selling and Administration Expenses for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Acadia Pharmaceuticals ACAD:US USD 78.11M 11.79M
Agios Pharmaceuticals AGIO:US USD 29.12M 859K
Alnylam Pharmaceuticals ALNY:US USD 235.86M 65.88M
Amgen AMGN:US USD 1.29B 40M
Arrowhead Research ARWR:US USD 32.74M 1.12M
Avrobio Inc AVRO:US USD 7.07M 1.83M
Biocryst Pharmaceuticals BCRX:US USD 36.92M 1.1M
Biomarin Pharmaceutical BMRN:US USD 216.82M 19.98M
Bluebird Bio BLUE:US USD 33.4M 3.29M
Intercept Pharmaceuticals ICPT:US USD 43.27M 3.29M
IONIS PHARMACEUT IONS:US USD 34.42M 614K
Mirati Therapeutics MRTX:US USD 60.8M 6.57M
Moderna Inc MRNA:US USD 278M 67M
Neurocrine Biosciences NBIX:US USD 186.3M 3.5M
Novartis NVS:US USD 3.4B 185M
Ptc Therapeutics PTCT:US USD 80.12M 226K
Regeneron Pharmaceuticals REGN:US USD 529.1M 52.8M
Regulus Therapeutics RGLS:US USD 2.25M 214K
Sangamo Biosciences SGMO:US USD 16.24M 1.14M
Sarepta Therapeutics SRPT:US USD 104.79M 49.53M
Takeda 4502:JP JPY 248.73B 17.25B
Ultragenyx Pharmaceutical RARE:US USD 69.84M 1.7M
Vertex Pharmaceuticals VRTX:US USD 246.8M 31.5M
Xencor XNCR:US USD 12.37M 1.28M
YTE INCY:US USD 266.46M 13.18M